“Immunotherapy: a new therapeutic option for the treatment of NSCLC”

Immunotherapy has recently emerged as a new therapeutic option for the treatment of NSCLC.
The introduction of it into the daily clinical practice has required a greater dissemination of information related to this therapeutic strategy, both among patients and physicians.
This anonymous survey has been developed in order to assess the level of knowledge, understanding and information that is provided to lung cancer patients and to assess any problems that patients and patient organizations may observe with the advent of the Immunotherapy.

Thank you for your participation.

https://it.surveymonkey.com/r/Immunotherapy_engl

Comments are closed.